January 18, 2012 Sample preparation & protein enrichment for proteomics and mass spectrometry Helen Kim 934-3880 [email protected] Dept of Pharmacology and Toxicology McCallum Building, room 460 http://www.uab.edu/proteomics Jan 18, 2012 HelenKim/UAB/PharmTox 1 Learning objectives • “Smart” proteomics: – lowest proteome complexity, highest biological specificity • How do we achieve lowest proteome complexity: – Purify according to intrinsic properties – Purify according to biological properties – Enrich for subcellular compartments • If the chemistry in sample preparation has been ignored, or hasn’t been dealt with properly, the most “pure” proteomics sample will give lousy mass spectra. Jan 18, 2012 HelenKim/UAB/PharmTox 2 The basic elements of intact protein proteomics: (1) separation, (2) processing for MS analysis, (3) identification and characterization trypsin 2647.50 1705.16 1838.26 1937.22 1994.24 2137.21 2284.25 2384.27 5000 684.11 10000 1461.00 http://www.matrixscience.com 15000 789.57 MASCOT search engine Counts ID of parent polypeptide 1122.79 1165.80 1277.83 1048.72 MALDI-TOF mass spectrometry 0 1000 Jan 18, 2012 HelenKim/UAB/PharmTox 1500 2000 2500 Mass (m/z) 3 3000 Handling proteins and peptides • Collecting and storing the sample – Use the same type of storage device for all the samples in a study…quality control!! – Some samples are sensitive to freezing • Mitochondria and other organelle fractions should be prepared using fresh tissue • Samples especially fluids and organelle preparations should be placed in same volume aliquots and only thawed one time to avoid the effects of multiple freeze-thaw cycles – Freeze fast (into liquid N2) • Buffers such as sodium phosphate can selectively precipitate while ice and water are in equilibrium (down to -20oC) - this can lead to a substantial change in pH • Similarly, thaw fast rather than slowly, then keep on ice. (thaw by running between your hands, vs letting it sit on bench while you eat lunch. Jan 18, 2012 HelenKim/UAB/PharmTox 4 Tissue disruption/cell lysis • Manual and mechanical homogenization – Pestle and mortar, Dounce and PotterElvehjem homogenizers, Waring blender, Polytron • Grinding with beads, sonication and freeze-thaw • Osmotic shock - or not! • BugbusterTM for bacteria • Detergents: CHAPS, Triton X-100, cholate and deoxycholate • Protease inhibitors Jan 18, 2012 HelenKim/UAB/PharmTox 5 Parameters that govern the choice of protein separation method • • • • Purity of protein Speed of purification Quantity of protein What is the question:most important – Discovering a new protein/proteome – Identifying protein-protein interactions – Identifying potential modifications of known proteins Jan 18, 2012 HelenKim/UAB/PharmTox 6 Properties of polypeptides that enable separation from each other • Intrinsic properties – Size—number of amino acids – Net Charge • Biological/functional properties – – – – Intracellular location Enzyme activity Undergoes oligomerization Undergoes modification Jan 18, 2012 HelenKim/UAB/PharmTox 7 Some protein separation methods are both preparative and analytical • 2D electrophoresis – Resolves polypeptides dissociated from each other – Good for isoform detection/quantitation, PTM changes detection/quantitation • 2D blue native electrophoresis: – Resolves complexes containing intact proteins – Can be quantified by MS, or by blotting for specific proteins Jan 18, 2012 HelenKim/UAB/PharmTox 8 Separating proteins by size • For purification: Gel filtration chromatography • Analytic: SDS-PAGE Jan 18, 2012 HelenKim/UAB/PharmTox 9 Separating proteins by charge • Purification: Ion exchange chromatography • Analytic: isoelectric focussing • But may use SDS-PAGE to monitor purification Jan 18, 2012 HelenKim/UAB/PharmTox 10 Protein functional properties that can be basis for purification • Oligomerization: – Each cytoskeletal component undergoes reversible oligomerization from its monomers • Intracellular location: – Change in – Increase in same location • Protein-protein interaction Jan 18, 2012 HelenKim/UAB/PharmTox 11 Wide dynamic range for proteins in most cells: rationale for protein enrichment • A gel that is overloaded with respect to the abundant proteins, may still have only barely detectable or nondetectable amounts of a low abundance protein – If you can t see it, you don’t know it’s there; – Even if software detects and quantitates it, you can t do MS of it, because there isn’t enough protein. • No one stain will detect 9 orders of magnitude differences in abundance of proteins. • In MS experiments, bypassing gels, the greater the complexity of the peptide mixture, the lower the chance of detecting very low abundance proteins/ peptides. Jan 18, 2012 HelenKim/UAB/PharmTox 12 Use “old” information and “conventional” approaches like differential centrifugation to enhance proteomics experiments. hypotonic lysis and/or homogenization Nucleus (pellet) 1,000xg supernatant 10,000xg 100,000xg supernatant + membranes, vesicles Jan 18, 2012 Mitochondria (pellet) cytosol HelenKim/UAB/PharmTox 13 Analysis of mitochondrial proteins enhanced by purifying that subproteome Whole Rat Liver Rat Liver Mitochondria 3 10 3 10 2D gel analysis using the Invitrogen ZOOM system (Courtesy of Shannon Bailey Lab – Whitney Theis and Kelly Andringa) Jan 18, 2012 HelenKim/UAB/PharmTox 14 The good news: Several subcellular proteomes have been catalogued. Compartment # polypeptides in SWISSPROT as of 2000 Mitochondria (1000/cell) 269------5% of total Lysosome (400/cell) 50------1% of total Peroxisome 35------0.6% ER and Golgi apparatus 157------3% Nuclei (5% cell volume) 964-----17% Others (cytosol, membrane) 4228----75% total: 5703 (Jung et al. [2000] Electrophoresis) Note date: this is old!!! But the principle is the same; homework for class, find current numbers, please. Jan 18, 2012 HelenKim/UAB/PharmTox 15 Antibodies can reduce the complexity of the proteome, as well as enhance biological specificity, by 10,000-fold A cell lysate: 6,739 polypeptides An immune complex of 1-10 polypeptides (why might there be more than one polypeptide?) Which sample would you rather deal with on a 1D or 2D gel? Jan 18, 2012 HelenKim/UAB/PharmTox 16 2D Western blot + Mass spectrometry identified colitogenic antigens from a particular bacterium Stained 2D gel of one lysate Western Blot A B C D E F G H I J K L M N! Bacterial lysates probed with mouse serum Duplicate 2D gel Western blotted with the same serum MS Jan 18, 2012 gi|29338205 Mass: 45415 MOWSE Score: 100 Putative identification: tetratricopeptide repeat family protein [Bacteroides thetaiotaomicron VPI-5482] HelenKim/UAB/PharmTox 17 (Elson et al., unpublished data) 2D DIGE of immunoprecipitates to determine tubulin-binding proteins A B Overlay of A and B images GREEN (A): starting tubulin and MAPs RED (B): antibody alone, 8 ug Conclusion: tubulin, MAPs and antibody resolved from Jan 18, 2012 HelenKim/UAB/PharmTox 18 each other, without having to deplete of antibody Complexity in initial 2D analysis of tubulin immunoprecipitates: Something in the MAPs coprecipitates with anti-tubulin A B A and B overlay GREEN (A): pellet of anti-tubulin + MAPs, no tubulin (commercial preparation); RED (B): pellet of anti-tubulin + tubulin, no MAPs; YELLOW: in both pellets; IDEALLY, Jan 18, 2012 proteins common HelenKim/UAB/PharmTox there should be no green 19 Affinity purification: Antibodies are available for many protein posttranslational modifications • Phosphorylation • Glycosylation • Oxidative modifications: – Protein carbonyls – Reactive aldehyde adduct formation: 4HNE • Keep in mind that these modifications each involve mass changes, thus can be detected directly by MS. Jan 18, 2012 HelenKim/UAB/PharmTox 20 Structures important in protein electrophoresis to know 2 1 4 3 6 7 5 Jan 18, 2012 HelenKim/UAB/PharmTox 21 The action of a “reductant” A disulfide bond “the reductant” (believe it or not, from Wikipedia, 2011) Jan 18, 2012 HelenKim/UAB/PharmTox 22 The interplay of protein structure and SDS: Single mutations in a hairpin sequence affect mobility of an intact polypeptide on SDS-PAGE. (Taken from Rath et al., PNAS 2009) Jan 18, 2012 ©2009 by National Academy of Sciences HelenKim/UAB/PharmTox 23 Relationship between hairpin conformation and detergent binding. (Taken from Rath et al., PNAS 2009) Jan 18, 2012 ©2009 by National Academy of Sciences HelenKim/UAB/PharmTox 24 Correlation of SDS binding and hydropathy. (Taken from Rath et al., PNAS 2009) Jan 18, 2012 ©2009 by National Academy of Sciences HelenKim/UAB/PharmTox 25 SDS-binding and mobility on SDS gels. (Taken from Rath et al., PNAS 2009) Jan 18, 2012 ©2009 by National Academy of Sciences HelenKim/UAB/PharmTox 26 Why do we care about SDS binding and minute differences in protein structure: • Western blot analysis can detect a polypeptide at an unexpected mw; doesn’t mean its mass is different necessarily in the mutant or diseased tissue; • Western blot detection of multiple bands may reflect structural or conformational heterogeneity in that one protein in the sample, not cross-reactivity with other proteins. • Cannot presume a polypeptide will be at or near its predicted or WT mw. Jan 18, 2012 HelenKim/UAB/PharmTox 27 Wide dynamic range for proteins in most cells: rationale for protein enrichment • A gel that is overloaded with respect to the abundant proteins, may still have only barely detectable or nondetectable amounts of a low abundance protein – If you can t see it, you don’t know it’s there; – Even if software detects and quantitates it, you can t do MS of it, because there isn’t enough protein. • No one stain will detect 9 orders of magnitude differences in abundance of proteins. • In MS experiments, bypassing gels, the greater the complexity of the peptide mixture, the lower the chance of detecting very low abundance proteins/ peptides. Jan 18, 2012 HelenKim/UAB/PharmTox 28 Benefit of removing salt from tryptic digest 1929.87 100 90 1993.962209.97 80 % Intensity 8477.0 1868.97 70 60 2148.00 2897.04 1804.90 Salt Contamination 2225.00 50 40 30 20 10 0900 1520 2140 2760 Mass (m/z) 1804.96 100 Trypsin autolysis peak % Intensity 90 80 30 20 2148.00 1475.78 Jan 18, 2012 ZipTip (desalting) 1928.96 1868.94 2290.10 1439.74 2383.97 1179.65 2706.12 2502.28 10 0 899.0 2.7E+4 1994.97 60 40 0 4000 2164.04 70 50 3380 1519.2 2139.4 2759.6 Mass (m/z) 3024.06 3379.8 HelenKim/UAB/PharmTox 0 4000.0 29 Preparing proteins for peptide mass fingerprinting (1) • The mass spectrometry procedure has to be preceded by high resolution protein chromatography steps……the LC part of LC-MS. • Or, it can be a sample with a few intense bands of interest - e.g., a recombinantly expressed protein in bacteria lysate. • SDS-PAGE may be the best thing you can do for your protein preparation…it gets rid of lots of potential contaminants, and at the same time concentrates the proteins into “bands.” Jan 18, 2012 HelenKim/UAB/PharmTox 30 Preparing proteins for peptide mass fingerprinting (2) • Once the protein is precipitated in the SDS gel matrix, electrolytes/salts and the SDS are largely removed by washing the gel pieces with 50% aqueous acetonitrile containing 25 mM NH4HCO3 buffer, pH 8 • The gel is dehydrated and rehydrated in 25 mM NH4HCO3 buffer, pH 8 to which trypsin added for overnight digestion. • The resulting peptides are extracted with 50% aqueous acetonitrile containing 25 mM NH4HCO3 buffer, pH 8 - the extract is evaporated, and brought up in MS-compatible buffer/solvent. Jan 18, 2012 HelenKim/UAB/PharmTox 31 Activity-based protein profiling (ABPP) to increase biological specificity of proteomic anslysis Jan 18, 2012 (Taken from Bogyo, PNAS, Feb, 2010) HelenKim/UAB/PharmTox 32 Tandem orthogonal proteolysis-activitybased protein profiling (TOP-ABPP): reducing complexity and increasing biological specificity at the same time CC reagents: Click chemistry is at the heart of this (Weerapana, Speers, Cravatt, Nature Protocols, Jan 18, 2012 HelenKim/UAB/PharmTox 33 Take home messages regarding protein purification • Reduce complexity of proteome – by conventional protein separation approaches (size exclusion, ion exchange, reverse phase). – Let biology work for you • Enrich for subcellular compartment • Affinity chromatography indicated by response to ligand • Oligomerization, protein-protein interactions • Choice of purification/separation approach governed by – – – – Abundance of sample Abundance (if known) of protein in question Question being asked What technologies you can access readily • LAST BUT NOT LEAST: What you can afford Jan 18, 2012 HelenKim/UAB/PharmTox 34 Take home points, part II • • • • • • What proteomics technology gives back is like any other analytical approach: the quality is as good as what you put in; Be mindful of distinguishing between low abundance proteins versus low level contaminants; Keep in mind conventional approaches like Western blotting to validate proteomic results; Purify, purify, purify before running any proteomic experiment. Formulating a hypothesis forces you to incorporate biological information that can enhance proteomic analysis. The “end result” in proteomics is just a beginning: I. II. III. Some changes are causal to the disease/phenotype; Some are real but not causal; Some could be response of the cells/tissues TO the disease, not causing the disease. Jan 18, 2012 HelenKim/UAB/PharmTox 35 Suggested readings • Cañas et al., 2007. Trends in sample preparation for classical and second generation proteomics Journal of Chromatography A, vol. 1153, pp 235-258. • Ishihama Y, Rappsilber J, Mann M. Modular stop and go extraction tips with stacked disks for parallel and multidimensional peptide fractionation in proteomics. J Proteome Res. 2006 Apr;5(4):988-94. • Durbin KR, Tran JC, Zamdborg L, Sweet SMM, Catherman AD, Lee JE, Li M, Kellie JF, Kelleher NL, Intact mass detection, interpretation, and visualization to automate TopDown proteomics on a large scale. PROTEOMICS Special Issue: Focus on Top-Down Proteomics 10 (20): 3589–3597, 2010. 2012 HelenKim/UAB/PharmTox 36
© Copyright 2024